Saudubray T, Saudubray C, Viboud C, Jondeau G, Valleron A-J, Flahault A, Hanslik T
Inserm U707, épidémiologie, système d'information, modélisation, faculté de médecine Saint-Antoine, université Paris 6, Paris, France.
Rev Med Interne. 2005 Nov;26(11):845-50. doi: 10.1016/j.revmed.2005.04.038.
Epidemiological data on heart failure's epidemiology in France are scarce and mostly hospital based. The present study's objective is to estimate the prevalence of heart failure (HF) and its management, in subjects aged 60 years and older seen by the French general practitioners (GP).
A standardised questionnaire was mailed to 900 GPs of the Sentinelles network, requiring answers for any patient aged 60 years and more, seen on a randomly assigned single day of year 2002. National census and health insurance data were used to estimate prevalence.
434 GPs answered, reporting data for 1797 patients aged 60 years and more. The 214 patients with HF, aged 79 years on average, had been seen by a cardiologist in 95% of cases. Results of an echocardiography was available for 58% of HF patients. Compared to non-HF patients, patients with HF were significantly more dependent, more frequently requiring home visit of the GP and more frequently hospitalised (p < 0.001, age adjusted). All the 42% HF patients with a reported left ventricle ejection fraction lower than 40% were treated with an angiotensin converting enzyme inhibitor or an angiotensin receptor inhibitor. The prevalence of HF among patients aged 60 years and older was estimated at 11.9% in general practice (95% confidence interval: 10.5-13.5), and at 2.19% (1.9-2.5) in the general population. The prevalence increased with age, over 20% in persons aged 80 years and more.
HF in patients aged 60 years and more seen in general practice in France is characterised by a high prevalence and medical consumption in terms of required number of hospitalisation and GP's home visit. For the GP, the diagnosis of HF relies on the cardiologist more than on an echocardiography. The therapeutic management seems to fit the actual recommendations.
法国关于心力衰竭流行病学的资料匮乏,且大多基于医院数据。本研究旨在估计法国全科医生诊治的60岁及以上患者中心力衰竭(HF)的患病率及其管理情况。
向Sentinelles网络的900名全科医生邮寄了一份标准化问卷,要求他们提供2002年随机指定的某一天所诊治的60岁及以上患者的相关信息。利用全国人口普查和医疗保险数据来估计患病率。
434名全科医生进行了回复,报告了1797名60岁及以上患者的数据。214名心力衰竭患者的平均年龄为79岁,其中95%的患者曾看过心脏病专家。58%的心力衰竭患者有超声心动图检查结果。与非心力衰竭患者相比,心力衰竭患者的依赖性明显更强,更频繁地需要全科医生上门诊疗,住院频率也更高(年龄调整后,p<0.001)。所有报告左心室射血分数低于40%的42%的心力衰竭患者均接受了血管紧张素转换酶抑制剂或血管紧张素受体抑制剂治疗。在全科医疗中,60岁及以上患者心力衰竭的患病率估计为11.9%(95%置信区间:10.5 - 13.5),在普通人群中为2.19%(1.9 - 2.5)。患病率随年龄增长而增加,80岁及以上人群中超过20%。
在法国全科医疗中,60岁及以上患者的心力衰竭具有患病率高以及在住院次数和全科医生上门诊疗方面医疗资源消耗大的特点。对于全科医生而言,心力衰竭的诊断更多依赖心脏病专家而非超声心动图检查。治疗管理似乎符合实际建议。